This inventor holds 1 USPTO granted patent. Top assignee: Tzu Chi University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Chia-Chen Lau: Innovator in Anti-Oral Cancer Drug Development
Introduction
Chia-Chen Lau is a notable inventor based in Jhubei, Taiwan. He has made significant contributions to the field of cancer research, particularly in the development of anti-oral cancer drugs. His innovative work focuses on utilizing unique chemical compounds to combat the proliferation of cancer cells.
Latest Patents
Chia-Chen Lau holds a patent for the "Use of a polyenylpyrrole derivative in preparation of anti-oral cancer drugs." This invention discloses the application of a polyenylpyrrole derivative synthesized from polyvinylpyrrole, auxarconjugatin A, and 12E-isorumbrin. The compound has been shown to inhibit cell proliferation, migration, tumor sphere formation abilities, and xenograft tumorigenicity of oral cancer cells. He has 1 patent to his name.
Career Highlights
Lau is affiliated with Tzu Chi University, where he conducts his research and development work. His academic background and research focus have positioned him as a key player in the fight against oral cancer. His dedication to innovation in this field is evident through his patent and ongoing research efforts.
Collaborations
Chia-Chen Lau collaborates with esteemed colleagues such as Kuo-Feng Hua and Yulin Lam. Their combined expertise enhances the research initiatives at Tzu Chi University, fostering an environment of innovation and discovery.
Conclusion
Chia-Chen Lau's contributions to anti-cancer drug development highlight his commitment to advancing medical science. His innovative approach and successful patent demonstrate the potential for new treatments in the fight against oral cancer.